Short-term effects of oral ketamine for the treatment of depression: A systematic review and meta-analysis of randomized controlled trials.
Asian Journal of Psychiatry May 16, 2026 Sonia Shenoy, Vijetha Shenoy Belle, Ravindra Neelakanthappa Munoli et al. 1 citation
Background: Oral ketamine is a novel treatment for management of depression. However, evidence related to its effectiveness and safety is unavailable. This systematic review aimed to assess the short-term efficacy and safety of oral ketamine compared to placebo or other modes of ketamine in randomized controlled trials (RCT) in unipolar depression, bipolar depression, and treatment-resistant...
DOI: 10.1016/j.ajp.2026.105014 (opens in new tab)
Depression
Humans
Antidepressive agents
Administration, oral
+4